
Opinion|Videos|May 17, 2024
Research Landscape: Endocrine Therapies for ER+/HER2- Metastatic Breast Cancer
Author(s)Stephanie L. Graff, MD
Stephanie Graff, MD, concludes the discussion with thoughts on endocrine therapies in development for patients with ER+/HER2- metastatic breast cancer.
Advertisement
Episodes in this series

Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
By Improving Sleep, TNX-102 SL Reduces Pain and Fatigue in Fibromyalgia
2
Health Insurance CEOs Questioned by House Committee About Rising Costs in Health Care
3
FDA Draft Guidance Proposes CR, MRD to Accelerate MM Drug Approval
4
SGLT2 Inhibitors Linked to Lower Risk of CKD, AKI Than GLP-1 RAs
5





























































